Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evgeni Levin

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Ebiomedicine|December 28, 2018
Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery diseaseMichiel J Bom, Evgeni Levin, Roel S Driessen, et al.
Plos One|December 7, 2017
Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational studyPieter F de Groot, Clara Belzer, Ömrüm Aydin, et al.
Frontiers in Immunology|September 2, 2025
An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn's disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytesAndrew Yung Fong Li Yim, Ishtu Hageman, Vincent W Joustra, et al.
Journal of the American Heart Association|March 28, 2018
Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic SyndromeLoek P Smits, Ruud S Kootte, Evgeni Levin, et al.
Gut|June 1, 2019
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit timePieter de Groot, Torsten Scheithauer, Guido J Bakker, et al.
Cardiovascular Research|January 30, 2024
Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS studyMoritz V Warmbrunn, Ulrika Boulund, Judith Aron-Wisnewsky, et al.
Nutrients|June 27, 2024
Novel Proteome Targets Marking Insulin Resistance in Metabolic SyndromeMoritz V Warmbrunn, Harsh Bahrar, Nicolien C de Clercq, et al.
Gut|October 26, 2021
Duodenal <i>Anaerobutyricum soehngenii</i> infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over studyAnnefleur Koopen, Julia Witjes, Koen Wortelboer, et al.
Diabetologia|January 10, 2020
Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trialPieter F de Groot, Tatjana Nikolic, Sultan Imangaliyev, et al.
Hepatology Communications|November 9, 2020
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With SteatohepatitisJulia J Witjes, Loek P Smits, Ceyda T Pekmez, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Ebiomedicine|December 28, 2018
Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery diseaseMichiel J Bom, Evgeni Levin, Roel S Driessen, et al.
Plos One|December 7, 2017
Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational studyPieter F de Groot, Clara Belzer, Ömrüm Aydin, et al.
Frontiers in Immunology|September 2, 2025
An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn's disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytesAndrew Yung Fong Li Yim, Ishtu Hageman, Vincent W Joustra, et al.
Journal of the American Heart Association|March 28, 2018
Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic SyndromeLoek P Smits, Ruud S Kootte, Evgeni Levin, et al.
Gut|June 1, 2019
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit timePieter de Groot, Torsten Scheithauer, Guido J Bakker, et al.
Cardiovascular Research|January 30, 2024
Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS studyMoritz V Warmbrunn, Ulrika Boulund, Judith Aron-Wisnewsky, et al.
Nutrients|June 27, 2024
Novel Proteome Targets Marking Insulin Resistance in Metabolic SyndromeMoritz V Warmbrunn, Harsh Bahrar, Nicolien C de Clercq, et al.
Gut|October 26, 2021
Duodenal <i>Anaerobutyricum soehngenii</i> infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over studyAnnefleur Koopen, Julia Witjes, Koen Wortelboer, et al.
Diabetologia|January 10, 2020
Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trialPieter F de Groot, Tatjana Nikolic, Sultan Imangaliyev, et al.
Hepatology Communications|November 9, 2020
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With SteatohepatitisJulia J Witjes, Loek P Smits, Ceyda T Pekmez, et al.
Pageof 6